These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 8137036)

  • 21. Effects of HMG-CoA reductase inhibition on PDGF- and angiotensin II- mediated signal transduction: suppression of c-Jun and c-Fos in human smooth muscle cells in vitro.
    Kreuzer J; Watson L; Herdegen T; Loebe M; Wende P; Kübler K
    Eur J Med Res; 1999 Apr; 4(4):135-43. PubMed ID: 10205288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Statins (HMG-CoA reductase inhibitors), cholesterol and stroke].
    Marta-Moreno J; Echeandia C; Oliveros-Cid A; Figuerola A; Mola S
    Rev Neurol; 1998 Nov; 27(159):827-30. PubMed ID: 9859160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs.
    Davis HR; Pula KK; Alton KB; Burrier RE; Watkins RW
    Metabolism; 2001 Oct; 50(10):1234-41. PubMed ID: 11586500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of hypocholesterolaemic agents on the expression and activity of 3-hydroxy-3-methylglutaryl-CoA reductase in the fat body of the German cockroach.
    Zapata R; Martín D; Piulachs MD; Bellés X
    Arch Insect Biochem Physiol; 2002 Apr; 49(4):177-86. PubMed ID: 11921076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of five HMG-CoA reductase inhibitors-- atorvastatin, lovastatin, pravastatin, rosuvastatin and simvastatin: pharmacological, pharmacokinetic and analytical overview and development of a new method for use in pharmaceutical formulations analysis and in vitro metabolism studies.
    Pasha MK; Muzeeb S; Basha SJ; Shashikumar D; Mullangi R; Srinivas NR
    Biomed Chromatogr; 2006 Mar; 20(3):282-93. PubMed ID: 16143964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HMG CoA reductase inhibitors and quality of life.
    Downs JR; Oster G; Santanello NC
    JAMA; 1993 Jun 23-30; 269(24):3107-8. PubMed ID: 8505809
    [No Abstract]   [Full Text] [Related]  

  • 27. Does vitamin E beneficially affect muscle pains during HMG-Co-enzyme-A-reductase inhibitors without CK-elevation?
    Sinzinger H
    Atherosclerosis; 2000 Mar; 149(1):225. PubMed ID: 10799017
    [No Abstract]   [Full Text] [Related]  

  • 28. Role of interleukin-12 and - 18 in lupus-like syndrome patients with statin use: comment on: Association between statin use and lupus-like syndrome using spontaneous reports.
    Park SJ; Shin JI
    Semin Arthritis Rheum; 2012 Jun; 41(6):e2-3. PubMed ID: 22405028
    [No Abstract]   [Full Text] [Related]  

  • 29. Statins in systemic lupus erythematosus.
    Abud-Mendoza C
    Ann Rheum Dis; 2018 Sep; 77(9):e60. PubMed ID: 28993343
    [No Abstract]   [Full Text] [Related]  

  • 30. Response to: 'Statins in systemic lupus erythematosus' by Abud-Mendoza.
    de Jong HJI; van Staa TP; Cohen Tervaert JW
    Ann Rheum Dis; 2019 May; 78(5):e43. PubMed ID: 29358283
    [No Abstract]   [Full Text] [Related]  

  • 31. Hyperkalemia during treatment with HMG-CoA reductase inhibitor.
    Edelman S; Witztum JL
    N Engl J Med; 1989 May; 320(18):1219-20. PubMed ID: 2710198
    [No Abstract]   [Full Text] [Related]  

  • 32. Comment on "Cardiovascular risk stratification and appropriate use of statins in patients with systemic lupus erythematosus according to different strategies".
    Cure E; Cumhur Cure M
    Clin Rheumatol; 2020 Feb; 39(2):615-616. PubMed ID: 31927712
    [No Abstract]   [Full Text] [Related]  

  • 33. Recurrent hyperthermia due to lovastatin.
    von Pohle WR
    West J Med; 1994 Oct; 161(4):427-8. PubMed ID: 7817565
    [No Abstract]   [Full Text] [Related]  

  • 34. [Myopathy caused by inhibitors of hydroxymethylglutaryl-coenzyme A reductase].
    Martinez-García FA; Martín-Fernández J; Moltó JM; Villaverde R; Morales A; Fernández-Barreiro A
    Rev Neurol; 1997 Jun; 25(142):869-71. PubMed ID: 9244616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [HMG-CoA reductase inhibitors and sexual dysfunction].
    Pía Iglesias G; Fernández Fernández FJ; Ameneiros Lago E; Sesma Sánchez P
    An Med Interna; 2001 Mar; 18(3):171. PubMed ID: 11594194
    [No Abstract]   [Full Text] [Related]  

  • 36. Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors.
    Tobert JA
    Nat Rev Drug Discov; 2003 Jul; 2(7):517-26. PubMed ID: 12815379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Side effects of HMG CoA reductase inhibitors.
    Ahmad S
    Heart Dis Stroke; 1993; 2(3):262-3. PubMed ID: 8137036
    [No Abstract]   [Full Text] [Related]  

  • 38. Lupuslike syndrome associated with simvastatin.
    Bannwarth B; Miremont G; Papapietro PM
    Arch Intern Med; 1992 May; 152(5):1093. PubMed ID: 1510761
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.